There are several examples in atopic dermatitis of transgenic mice that overexpress type 2 cytokines under keratin promotors (e.g., K14-IL4+K5-IL13, K5-TSLP, K14-IL33) that develop AD-like skin disease (27). This evidence concerns the gene KRT14 and atopic eczema.